other material
confidence high
sentiment neutral
materiality 0.15
Bicara Therapeutics files amended charter and bylaws post-IPO, increases authorized shares to 500M
Bicara Therapeutics Inc.
- Authorized 500 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated stockholder ability to act by written consent and to call special meetings.
- Established advance notice procedures for stockholder proposals and director nominations.
- Amendments effective immediately prior to completion of IPO, as previously disclosed in S-1.